Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

§
Marginalia
Code · BILL · 116th Congress · H.R. 4764 (Received in Senate) — To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. · Sec. 5

Sec. 5. GAO report on regenerative medicine workforce

268 words·~1 min read·/bill/116/hr/4764/rds/section-5

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Not later than 2 years after the date of enactment of this Act, the Comptroller General of the United States shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report that assesses the national blood stem cell workforce, including those related to the C.W. Bill Young Cell Transplantation Program established under section 379 of the Public Health Service Act ( 42 U.S.C. 274k ).
The report shall include— an overview of the current employment levels, in both commercial and academic settings, for— positions necessary for the collection and transplantation of stem cell therapeutics, including bone marrow and cord blood; positions in the field of regenerative medicine using adult stem cells and related to product development; and Federal funding for extramural stem cell programs; an overview of the current employment levels in Federal stem cell programs, including the scope of, staffing models of, and vacancies within such programs; the identification of gaps, if any, in the projected workforce capacity for— positions described in paragraph (1)(A); and the field of regenerative medicine using adult stem cells, including workforce gaps related to the development of new cellular therapies using adult stem cells; an overview of the availability of training programs related to the development, refinement, and utilization of adult stem cells, including training on good manufacturing practices for such activities, and the performance of such programs; and recommendations, if any, for improving the workforce capacity related to— the positions described in paragraph (1)(A); or the field of regenerative medicine using adult stem cells.
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 5
GAO report on regenerative medicine workforce
U.S.C.§ 274k
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.